Stay updated on ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Sign up to get notified when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.

Latest updates to the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now lists the Study Contact and Investigator details with direct contact information (jen.olson@alleviantmedical.com, +1 612 327 2741) and names of multiple investigators and sites. The recruitment status is shown as Recruiting with an updated 93-location site count, and several previously listed locations and the 'Enrolling by invitation' status were removed.SummaryDifference14%

- Check15 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor update to the page's underlying template or rendering.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4 on the page.SummaryDifference0.0%

- Check58 days agoChange DetectedThe revision tag at the bottom of the page changed from v3.6.0 to v3.6.3. This indicates a platform update, while the study details and content appear unchanged.SummaryDifference0.0%

- Check73 days agoChange DetectedAdds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and includes an updated Intervention/Treatment label. The revision tag is updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check80 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, signaling a small platform/documentation update rather than changes to study details or results.SummaryDifference0.0%

Stay in the know with updates to ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.